Principal Securities’s Novartis NVS Stock Holding History
Bought
Maintained
Sold
Other funds holding NVS
Principal Securities's NVS Position: Q1 2026 in Review
Principal Securities reduced its Novartis (NVS) stake by 8.4% in Q1 2026, selling an estimated $445K and leaving 31,464 shares worth $4.81M. The position accounts for 0.07% of the portfolio, ranked #270.
Principal Securities first reported a position in NVS in Q4 2023 and has held it in 10 quarters since. 1,590 funds tracked by Wall St. Rank hold NVS as of Q1 2026.
- Principal Securities held 31,464 shares of Novartis worth $4.81M as of Q1 2026.
- Principal Securities sold 2,904 Novartis shares in Q1 2026, an estimated $445K.
- Novartis made up 0.07% of Principal Securities's portfolio in Q1 2026, its #270 holding.
- Principal Securities first reported a position in Novartis in Q4 2023 and has held it in 10 quarters since.
- 1,590 funds tracked by Wall St. Rank held Novartis as of Q1 2026.
Based on Principal Securities's 13F filing for Q1 2026, filed 13 May 2026.